Exelixis Inc EXEL rose 20.13% to $5.67 in the pre-market session. EXEL has reported interim data from the patients with metastatic castration-resistant prostate cancer (CRPC) treated with XL184.
Dendreon Corporation DNDN added 9.14% to $39.15 in the pre-market session. A US advisory panel supported DNDN's prostate-cancer treatment Provenge.
DryShips Inc DRYS moved up 8.67% to $5.64 in the pre-market session. DRYS reported upbeat Q3 results.
Aruba Networks Inc ARUN soared 7.65% to $22.95 in the pre-market trading. ARUN swung to Q1 profit.
Read more from Benzinga's Markets.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Posted In: EarningsPre-Market OutlookIntraday UpdateMarketsMoversBiotechnologyCommunications EquipmentHealth CareIndustrialsInformation TechnologyLife Sciences Tools & ServicesMarineTop Pre-Market NASDAQ Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in